BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15722572)

  • 1. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowskal H; Strzelczyk J; Janiak A; Malecka-Panas E
    Hepatogastroenterology; 2006; 53(70):608-12. PubMed ID: 16995472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations.
    Banerjee SK; Zoubine MN; Mullick M; Weston AP; Cherian R; Campbell DR
    Pancreas; 2000 Apr; 20(3):248-55. PubMed ID: 10766450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
    Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
    J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
    Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras mutations at codon 12 are rare events in chronic pancreatitis.
    Orth M; Gansauge F; Gansauge S; Beger HG; Adler G; Schmid RM
    Digestion; 1998; 59(2):120-4. PubMed ID: 9586823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
    Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
    Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
    Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
    Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
    Tada M; Omata M; Ohto M
    Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
    Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
    Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
    Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
    JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.